← Back to Search

Improv Comedy Classes for Psychological Distress After Cancer (IMPROV2 Trial)

N/A

Waitlist Available

Research Sponsored by Arash Asher, MD

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult female age ≥18

Diagnosed with breast cancer stage 1-3 (no distant metastases)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

IMPROV2 Trial Summary

This trial is testing whether an improv class can help people with depression. 46 people will be randomly assigned to either the class or a waitlist control group. Assessments will be taken at various points before and after the class to see if there are any changes.

Who is the study for?

This trial is for adult women over 18 who have completed breast cancer treatment (stages 1-3, no distant metastases) at least 2 months ago but not more than 18 months prior. They must be medically stable, emotionally ready for group activities, speak English, and commit to attending most improv classes.Check my eligibility

What is being tested?

The study tests if improvisational comedy classes can help reduce psychological distress in breast cancer survivors. Participants are randomly assigned to either start improv classes right away or placed on a waitlist control group with evaluations at multiple stages.See study design

What are the potential side effects?

Since the intervention involves comedy classes rather than medical treatments, there are no direct physical side effects expected. However, participants may experience varying levels of emotional comfort or discomfort during the sessions.

IMPROV2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a woman aged 18 or older.

Select...

My breast cancer is at stage 1 to 3 and has not spread far.

IMPROV2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Overall well-being

Secondary outcome measures

Anxiety

Depression

General self-efficacy

+3 more

IMPROV2 Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment1 Intervention

Group II: Waitlist Control GroupActive Control1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Tower Cancer Research FoundationUNKNOWN

2 Previous Clinical Trials

85 Total Patients Enrolled

Arash Asher, MDLead Sponsor

3 Previous Clinical Trials

66 Total Patients Enrolled

Media Library

Improvisational comedy classes Clinical Trial Eligibility Overview. Trial Name: NCT03824132 — N/A

Breast Cancer Research Study Groups: Intervention Group, Waitlist Control Group

Breast Cancer Clinical Trial 2023: Improvisational comedy classes Highlights & Side Effects. Trial Name: NCT03824132 — N/A

Improvisational comedy classes 2023 Treatment Timeline for Medical Study. Trial Name: NCT03824132 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has enrollment opened for this clinical experiment yet?

"Clinicaltrials.gov reports that this specific trial is not currently enrolling patients; however, it was first posted on August 2nd 2019 and last updated September 19th 2022. Fortunately, there are 1460 other trials actively searching for participants at the present moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

LOL: It's All Improv After Cancer!™

Arash Asher, MD 2019. "LOL: It's All Improv After Cancer!™". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03824132.

All > Breast Cancer Anaheim